No Data
No Data
JonesTrading Initiates Clene(CLNN.US) With Buy Rating, Announces Target Price $30
Optimistic Outlook on Clene's CNM-Au8 for ALS: Investment Potential Amid Clinical Challenges
Clene Initiated With a Buy at JonesResearch
Express News | Clene Inc. : Jonestrading Initiates Coverage With Buy Rating; Target Price $30
Express News | Clene Shares Are Trading Higher. HC Wainwright & Co. and D. Boral Capital Reiterated Buy Ratings on the Stock
Clene Price Target Maintained With a $23.00/Share by D. Boral Capital